GlassScriptPhysician profile
Clifford B Freling
NPI 1275529729
$538.61
in general payments reported to CMS, 2019-2025
9 companies · $38.33 in 2025
The $38.33 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.49 · 2020: $23.07 · 2021: $218 · 2022: $165 · 2023: $32.70 · 2025: $38.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $367.13 | 2021-2022 | |
| Varian Medical Systems, INC. | $38.33 | 2019 | |
| Boston Scientific Corporation | $23.56 | 2025 | Eluvia |
| Ekos Corporation | $23.16 | 2019 | |
| Bard Peripheral Vascular, INC. | $23.07 | 2020 | |
| Abbott Laboratories | $19.74 | 2023 | Jeti Peripheral Catheter |
| Abbvie INC. | $15.89 | 2022 | |
| Siemens Medical Solutions USA, INC. | $14.77 | 2025 | Somatom X.Cite |
| Inari Medical, INC. | $12.96 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifford Freling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.